CRISPR Therapeutics stock maintains Outperform rating at Oppenheimer
CRISPR Therapeutics stock maintains Outperform rating at Oppenheimer #CRISPR #Therapeutics #stock #maintains #Outperform #rating #Oppenheimer
Business News
OVS submits binding offer to acquire Italian retailer Kasanova
OVS submits binding offer to acquire Italian retailer Kasanova #OVS #submits #binding #offer #acquire #Italian #retailer #Kasanova
UK labour market loses more steam, bolstering BoE rate cut bets
UK labour market loses more steam, bolstering BoE rate cut bets #labour #market #loses #steam #bolstering #BoE #rate #cut #bets
Yen slips to 9-month low as traders eye end to US shutdown
Yen slips to 9-month low as traders eye end to US shutdown #Yen #slips #9month #traders #eye #shutdown
Sony raises profit forecast by 8% on lower tariff impact
Sony raises profit forecast by 8% on lower tariff impact #Sony #raises #profit #forecast #tariff #impact
Form 13G 1 800 FLOWERS COM INC For: 10 November
Form 13G 1 800 FLOWERS COM INC For: 10 November #Form #13G #FLOWERS #November
Vor Bio prices $100 million public offering of common stock
Vor Bio prices $100 million public offering of common stock #Vor #Bio #prices #million #public #offering #common #stock
CBA shares slide as lower interest rates, competition pressure margins
CBA shares slide as lower interest rates, competition pressure margins #CBA #shares #slide #interest #rates #competition #pressure #margins
Rollins stockholders price secondary offering at $57.50 per share
Rollins stockholders price secondary offering at $57.50 per share #Rollins #stockholders #price #secondary #offering #share
Intel CEO to oversee its AI efforts after executive departs for OpenAI
Intel CEO to oversee its AI efforts after executive departs for OpenAI #Intel #CEO #oversee #efforts #executive #departs #OpenAI